Major acute cardiovascular events in patients with inflammatory bowel disease

被引:7
|
作者
Gill, Gauravpal S. [1 ]
Fernandez, Stephen J. [2 ]
Malhotra, Nidhi [1 ,3 ]
Mete, Mihriye [2 ]
Garcia-Garcia, Hector M. [1 ]
机构
[1] MedStar Washington Hosp Ctr, Dept Med, Washington, DC USA
[2] MedStar Hlth Res Inst, Dept Biostat & Informat, Hyattsville, MD USA
[3] Georgetown Univ, Dept Med, Washington, DC USA
关键词
cardiovascular events; coronary artery disease; inflammatory bowel disease; outcomes;
D O I
10.1097/MCA.0000000000000899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Systemic inflammation and immune-mediated diseases have been associated with ischemic heart disease in addition to traditional risk factors. In this study, we investigate associations between inflammatory bowel disease (IBD) and acute cardiovascular events. Methods An observational study where patient data were extracted from our health system patient pool of 3 917 894. Propensity scores were calculated for all 15 292 patients (0.39%) with IBD to assemble a 1:1 matched cohort balanced for age, gender, race and known cardiovascular risk factors including hypertension, hyperlipidemia, diabetes mellitus and smoking (current and former). Secondary analyses were performed independently for 6658 patients with ulcerative colitis and 9406 patients with Crohn's disease. ICD-9 and ICD-10 codes were used to identify cardiovascular risk factors and outcomes. Results Matched patients (n = 30 584) had a mean age of 51 years, with 58% being women, and 63% Caucasian. During the median follow-up of 4.4 years, all-cause mortality was observed in 1.7 versus 1.2% of patients from IBD and non-IBD groups, respectively [hazard ratio, 1.31; 95% confidence interval (CI), 1.08-1.58; P = 0.005]. Combined outcome for myocardial infarction or cardiovascular mortality was noted in 2.3 and 2.1% from IBD and non-IBD groups, respectively (hazard ratio, 1.04; 95% CI, 0.90-1.21; P = 0.588), while hazard ratios for cardiovascular mortality, myocardial infarction and unstable angina were 1.04 (0.74-1.47; P = 0.833), 1.05 (0.89-1.23; P = 0.591) and 1.10 (0.83-1.46; P = 0.524), respectively. Conclusions Among patients with IBD, incidence of acute coronary events did not show a statistically significant difference when compared to the matched cohort.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [21] PREVALENCE AND BURDEN OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kandlakunta, Harika
    Patlolla, Sri Harsha
    Kandlakunta, Sriharsha
    Chalhoub, Jean M.
    GASTROENTEROLOGY, 2023, 164 (06) : S911 - S911
  • [22] Disease severity in patients with inflammatory bowel disease associated with cardiovascular diseases
    Mantaka, A.
    Tsoukali, E.
    Fragaki, M.
    Karmiris, K.
    Viazis, N.
    Mantzaris, G.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S521 - S521
  • [23] The Effect of Immunosuppressive Therapy on Cardiovascular Disease in Patients With Inflammatory Bowel Disease
    Thapa, Sudeep
    Hadid, Hiba
    Jafri, Syed-Mohammed
    Imam, Mohammed
    Schairer, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S481 - S481
  • [24] Predictors of Concomitant Coronary Artery Disease and Major Cardiovascular Events in Patients with Acute Ischemic Stroke
    Ileri, Cigdem
    Ozben, Beste
    Dogan, Zekeriya
    Sunbul, Murat
    Bulut, Burcu
    Tigen, Kursat
    Sayar, Nurten
    Midi, Ipek
    Basaran, Yelda
    NEUROLOGY INDIA, 2021, 69 (04) : 916 - 922
  • [25] Cerebral Thromboembolic Events in Pediatric Patients with Inflammatory Bowel Disease
    Barclay, A. R.
    Keightley, J. M.
    Horrocks, I.
    Garrick, V.
    McGrogan, P.
    Russell, R. K.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (04) : 677 - 683
  • [26] Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease
    Lopez-Martin, Cristina
    Chaparro, Maria
    Espinosa, Laura
    Bejerano, Alicia
    Mate, Jose
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (06): : 385 - 392
  • [27] Thrombophilias and thromboembolic events in a population of patients with inflammatory bowel disease
    Pinho, J.
    Martins, D.
    Sousa, P.
    Ministro, P.
    Cancela, E.
    Araujo, R.
    Castanheira, A.
    Silva, A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S168 - S169
  • [28] Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
    Gala, Dhir
    Newsome, Taylor
    Roberson, Nicole
    Lee, Soo Min
    Thekkanal, Marvel
    Shah, Mili
    Kumar, Vikash
    Bandaru, Praneeth
    Gayam, Vijay
    DISEASES, 2022, 10 (04)
  • [29] Acute major lower GI hemorrhage in inflammatory bowel disease.
    Pardi, DS
    Loftus, EV
    Tremaine, WJ
    Sandborn, WJ
    Alexander, GL
    Balm, RK
    Gostout, CJ
    GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 360 - 360
  • [30] The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease
    Mantaka, Aikaterini
    Tsoukali, Emmanouela
    Fragkaki, Maria
    Karmiris, Konstantinos
    Viazis, Nikos
    Mantzaris, Gerassimos J.
    Koutroubakis, Ioannis E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (05) : 581 - 587